Introduction

This policy fully supports the recommendations for clinical practice & training in transfusion medicine published by the National Institute of Health & Care Excellence (NICE), British Society for Haematology (BSH), the National Blood Transfusion Committee (NBTC), the Serious Hazards of Transfusion (SHOT) scheme & other national / local guidelines as referenced. This policy encompasses all blood components / products & has appendices covering guidance on specific issues as listed in the contents page

Ashford & St Peters NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals.

 

Scope of the Policy

All staff involved in sampling, prescribing, ordering, collecting, administration of blood components / products & care/monitoring of a patient receiving a transfusion must read the sections relevant to their place of work & role.

This policy applies to adult patients at Ashford & St Peters NHS Foundation Trust and the satellite hospitals that use blood components/products supplied by the Transfusion Laboratories.

 

Appendices

 

Policy Details

Download: PDF version
Compiled by: Kim East, Lead Transfusion Practitioner
Matthew Rogers, BSPS Lead for Transfusion Consultant Haematologist
Ratified by: ASPH Patient Blood Management Committee
BSPS Joint Patient Blood Management Team
Quality and Safety Committee
Date Ratified: August 2022
Date Issued: August 2022
Review Date: February 2023
Target Audience: All staff involved with blood transfusion and any associated blood products including anti-D and Beriplex.
Contact name: Kim East, Matthew Rogers